Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Patient clinical information

From: Whole genome sequencing reveals potential targets for therapy in patients with refractory KRASmutated metastatic colorectal cancer

  CLN2 CLN3 CLN4
Age at diagnosis 73 45 50
Gender male male male
Ethnicity Caucasian Caucasian Hispanic
Diagnosis Colon adenocarcinoma Rectal adenocarcinoma Colon adenocarcinoma
Tumor cellularity 60% 50% 30%
Sequenced biopsy Liver metastasis Right gluteal mass Right abdominal mass